Krish S. Krishnan, President and CEO at Krystal Biotech, Inc. (KRYS), sold 32,653 shares at $80.33 ($2.6M) on 2023-01-03, disclosed to the SEC on 2023-01-03.
Open-market sale of $2.6M KRYS by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.28 | 7,447 | $598K | 22.8% |
| 2 | $80.28 | 7,447 | $598K | 22.8% |
| 3 | $80.30 | 7,484 | $601K | 22.9% |
| 4 | $80.30 | 7,484 | $601K | 22.9% |
| 5 | $81.10 | 528 | $43K | 1.6% |
| 6 | $81.11 | 563 |
| $46K |
| 1.7% |
| 7 | $80.33 | 1,700 | $137K | 5.2% |
| Total | $80.32 avg | 32,653 | $2.6M | 100% |
| Filing → |
| KRYS | SELL | 2026-03-06 | $13.2M | — | Filing → |
| KRYS | SELL | 2025-12-05 | $20.9M | — | Filing → |
| KRYS | SELL | 2025-07-16 | $10.1M | — | Filing → |